Science
Mechanism of Action
This meroterpenoid, classified within the chromanol group, acts primarily as a powerful antioxidant. Its mechanism involves minimizing UVA-induced cellular damage and mitigating overall photodamage in exposed skin cells, thereby inhibiting the processes contributing to skin photoaging. Additionally, Sargachromanol D has shown hypopigmenting effects, suggesting an ability to lighten skin.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Sargachromanol D exhibits very low water solubility, estimated at 0.0008333 mg/L at 25 °C, supported by a high XLogP3 value of 6.4, indicating significant lipophilicity and oil-solubility. The optimal pH range for its stability within formulations is currently unknown.
Safety
Safety Profile
A comprehensive safety assessment by regulatory bodies such as CIR or SCCS is not available for Sargachromanol D. While listed in the FDA Global Substance Registration System (GSRS) and EPA CPDat, no specific GHS classification, hazard statements, or toxicity data (oral, dermal, inhalation) have been reported by available sources.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Sargachromanol D shows promising theoretical benefits for antioxidant, anti-photoaging, and skin-lightening applications, yet a lack of specific clinical efficacy and comprehensive safety data necessitates further rigorous research for definitive inclusion in precision skincare.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources